Proton Therapy Patient Registry
NCT02986048 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 999
Last updated 2026-04-09
Summary
The purpose of this study is to establish a database (or "registry") of patients treated with proton beam therapy at the University Hospitals (UH) Proton Therapy Center. By keeping track of the patients treated it will allow the investigators to periodically evaluate the outcomes of patients.
Conditions
- Treatment With Proton Beam Radiation Therapy
Interventions
- OTHER
-
Proton Beam Therapy
Intervention is not assigned. Only patient data is being collected
Sponsors & Collaborators
-
Case Comprehensive Cancer Center
lead OTHER
Principal Investigators
-
David B Mansur, MD · University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-22
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
Countries
- United States
Study Locations
More Related Trials
-
Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma
NCT00230386 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy
NCT03160794 ·Status: RECRUITING ·Phase: NA
-
Multi-parametric Magnetic Resonance Imaging for Prostate Cancer Patients
NCT03180398 ·Status: TERMINATED ·Phase: NA
-
Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era
NCT06508567 ·Status: RECRUITING ·Phase: NA
-
Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases
NCT05106699 ·Status: RECRUITING ·Phase: NA
-
Proton Therapy for Low and Intermediate Risk Prostate Cancer
NCT00693238 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer
NCT01540994 ·Status: COMPLETED ·Phase: NA
-
Hypofractionation Proton Beam Therapy With Concurrent Treatment of Prostate and Pelvic Nodes for Prostate Cancer
NCT02874014 ·Status: COMPLETED ·Phase: PHASE2
-
Multi-Institutional Registry for Prostate Cancer Radiosurgery
NCT01226004 ·Status: UNKNOWN
-
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
NCT00969111 ·Status: RECRUITING ·Phase: NA
-
Study of Quality of Life for Prostate Proton Therapy
NCT00489814 ·Status: UNKNOWN
-
Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer
NCT02163317 ·Status: COMPLETED ·Phase: NA
-
Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning
NCT02681614 ·Status: COMPLETED ·Phase: NA
-
Proton Boost in Prostate Cancer
NCT03564275 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial
NCT07130682 ·Status: RECRUITING ·Phase: NA
-
Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer
NCT00002602 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement
NCT06200259 ·Status: RECRUITING ·Phase: NA
-
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
NCT01492972 ·Status: RECRUITING ·Phase: PHASE3
-
External Beam Radiation Therapy - Target Volume
NCT00230438 ·Status: COMPLETED ·Phase: PHASE2
-
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
NCT06391034 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy
NCT03424850 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer
NCT00924313 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
CT/MRI Co-registration Prostate Cancer
NCT00252460 ·Status: COMPLETED
-
MR-simulation in Radiotherapy for Prostate Cancer
NCT03238170 ·Status: UNKNOWN ·Phase: NA
-
Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer
NCT02280356 ·Status: COMPLETED ·Phase: PHASE2